- Home
- THTX
as 11-15-2024 4:00pm EST
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
| Founded: | 1993 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 56.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 29.7K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.08 - $2.58 | Next Earning Date: | 10-10-2024 |
| Revenue: | $84,316,000 | Revenue Growth: | 5.75% |
| Revenue Growth (this year): | 5.6% | Revenue Growth (next year): | 4.62% |
Latest Theratechnologies Inc. News
THTX Breaking Stock News: Dive into THTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV
MT Newswires
a month ago
Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
GlobeNewswire
a month ago
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
Simply Wall St.
a month ago
Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
GuruFocus.com
a month ago
Theratechnologies Inc (THTX) Q3 2024 Earnings Call Highlights: Strong Profitability Amid ...
MT Newswires
a month ago
Theratechnologies Up 12% in U.S. Premarket Trading After Reporting Q3 Swing to Profit
Associated Press Finance
a month ago
Theratechnologies: Fiscal Q3 Earnings Snapshot
GlobeNewswire
a month ago
Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024
Compare THTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "THTX Theratechnologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.